United Kingdom · Report · Written statement
UIN HCWS1347
Clinical trials
Introduced
23 February 2026
Last action
23 February 2026 · Written statement
Status
Commons
Sponsors
—
Subjects
Discovery layer
Source updated
23 February 2026
Summary
Today, I am updating the House that the preliminary work to establish the PATHWAYS clinical trial into the prescription of puberty suppressants for children and young people with gender incongruence has been paused.The MHRA, the agency authorising the cli...
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
23 February 2026
Written statement
Today, I am updating the House that the preliminary work to establish the PATHWAYS clinical trial into the prescription of puberty suppressants for children and young people with gender incongruence has been paused.The MHRA, the agency authorising the cli...
Source: Commons
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-statements/detail/2026-02-23/HCWS1347
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenstatements/statements/1883420
- uk · ws-1883420 · source updated 23 February 2026